Falling for scams: an early sign of Alzheimer's?


Wednesday, 02 October, 2024


Falling for scams: an early sign of Alzheimer's?

Research suggests that changes in the brain linked to Alzheimer’s disease can also make older adults more susceptible to falling for scams.

A new Dornsife College of Letters, Arts and Sciences study at the University of Southern California used MRI scans to examine the brains of older people. It found that older adults with thinner brain regions linked to memory and decision-making — areas often affected early in Alzheimer’s — were more likely to be vulnerable to financial scams.

The study findings offer hope that financial vulnerability could be used as a simple screening tool to help identify early signs of cognitive decline, especially in people over 70.

How the study was conducted

Researchers led by Duke Han, professor of psychology and family medicine at USC Dornsife, aimed to better understand the link between early Alzheimer’s disease and financial vulnerability by using high-powered MRI to examine the brains of 97 study participants over age 50.

The scientists focused on the entorhinal cortex, a region that acts as a relay station between the hippocampus — the brain’s learning and memory centre — and the medial prefrontal cortex, which regulates emotion, motivation and other cognitive functions. It is often the first region to show changes in Alzheimer’s disease, typically becoming thinner as the disease progresses.

None of the study participants, aged between 52 and 83, showed clinical signs of cognitive impairment, but all underwent MRI scans to measure the thickness of their entorhinal cortex.

In addition, the researchers used a standardised tool called a perceived financial exploitation vulnerability scale (PFVS) to assess the participants’ financial awareness and their susceptibility to poor financial decisions, which they term “financial exploitation vulnerability”, or FEV.

By comparing the adults’ FEV with the thickness of their entorhinal cortex, Han and the team found a significant correlation: those more vulnerable to financial scams had a thinner entorhinal cortex.

This was especially true for participants aged 70 and older. Previous research has linked FEV to mild cognitive impairment, dementia and certain molecular brain changes associated with Alzheimer’s disease.

How the study results could be used

Han said the findings provide crucial evidence supporting the idea that FEV could be a new clinical tool for detecting cognitive changes in older adults — changes that are often difficult to detect.

“Assessing financial vulnerability in older adults could help identify those who are in the early stages of mild cognitive impairment or dementia, including Alzheimer’s disease,” Han said. He added, however, that financial vulnerability alone is not a definitive indicator of Alzheimer’s disease or other cognitive decline. “But assessing FEV could become part of a broader risk profile,” he said.

Han also noted several limitations of the study. Most participants were older, white, highly educated women, making it difficult to generalise the findings to a more diverse population. Additionally, while the study found a link between entorhinal cortex thickness and FEV, it does not prove one. Finally, the study does not include specific measures of Alzheimer’s disease pathology.

These limitations leave open the possibility that the relationship between FEV and entorhinal cortex thinning could be explained by other factors. Accordingly, Han said that more research — including long-term studies with diverse populations — is needed before FEV can be considered a reliable cognitive assessment tool.

Image credit: iStock.com/solidcolours

Related Articles

Cognitive impairment: why socioeconomic factors matter

The likelihood of developing cognitive impairment or dementia later in life is influenced by...

It's not just genetics that influence dementia: study

A new study by UNSW suggests that a range of social factors play a critical role in cognitive...

Study questions use of antidepressants in pain management

Despite a lack of evidence surrounding their efficacy, antidepressants are being used to treat...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd